Q4 2018 Holdings
Filed 2019-02-13 | 15 holdings | $24.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $24.7M | 3,061,091 | 99.5% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $25.4K | 1,284,931 | 0.1% |
| Orchard RX Ltd | COM | 68570P101 | $16.4K | 1,041,515 | 0.1% |
| Tricida Inc(1T7) | COM | 89610F101 | $15.3K | 650,585 | 0.1% |
| Obseva SA | COM | H5861P103 | $14.7K | 1,159,789 | 0.1% |
| Ra Pharmaceuticals | COM | 74933V108 | $10.8K | 594,713 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $9.2K | 327,777 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $5.0K | 2,388,572 | 0.0% |
| DBV Technologies | COM | 23306J101 | $4.1K | 636,800 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $3.6K | 1,258,964 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.8K | 423,176 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $2.7K | 848,610 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $1.8K | 2,274,370 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $704 | 869,538 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $267 | 66,667 | 0.0% |